Why is MAZE Up Today?

MAZE
$36.70
▲ +3.53% (+$1.29)
Last updated: Nov 11, 2026 8:30 PM ET

About Maze Therapeutics, Inc. Common Stock

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipel...

Sector: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Cap: $1.13B
Forward P/E: -10.5
52-Week Range: $21.95 - $53.65
Employees: 125

Overall Confidence: 60%

60% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 4.2%
This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

LOW VOLUME 0.4x average volume

UNCONFIRMED - Low volume suggests this move may not be sustainable.

📍 Sector Context

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -0.6%

MAZE is outperforming its sector by 4.2%. This suggests a stock-specific catalyst.

Market Comparison

MAZE is significantly outperforming the market (+2.2% vs SPY)
S&P 500
SPY
+1.32%
Nasdaq 100
QQQ
+2.31%
MAZE
This Stock
+3.53%
vs S&P 500: +2.21%
vs Nasdaq: +1.22%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, MAZE is expected to trade between:
$35.97 - $37.80

Key Level to Watch

$38.54 resistance
Watch for continuation above $36.70

🔔 Get MAZE Alerts

We'll notify you when MAZE's trend changes or a new signal fires.

Last updated: Nov 11, 2026 8:30 PM (-80 minutes ago)
Data refreshes every 30 minutes during market hours

Historical Context

MAZE has moved more than 3.0% up on 41 occasions in the past year.

51.2%
Continuation Rate
21/41 times continued up
+0.07%
Avg Next Day Change
After similar up moves
Last similar move: Nov 06, 2026 (5.1%) → Next day: +2.1%

Frequently Asked Questions

Why is MAZE stock up today?

This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

Is MAZE stock a buy or sell right now?

Based on current analysis, MAZE shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →

What is the MAZE stock price target?

MAZE is currently trading at $36.70. Based on today's momentum, the expected short-term range is $35.97 - $37.80. See long-term price prediction →

Will MAZE stock continue rising?

Our analysis shows a 45% probability that MAZE's move continues in the next 1-3 days. Key level to watch: $38.54 (resistance).

Is MAZE stock oversold or overbought?

MAZE's RSI (Relative Strength Index) is currently at 73.9. This indicates overbought conditions - the stock may be due for a pullback as buying pressure appears stretched.

What is the momentum for MAZE stock?

MAZE's 10-day momentum indicator is at 5.0. Strong bullish momentum - the stock is gaining significant upward force. This often precedes continued gains.

Is MAZE outperforming or underperforming the market?

MAZE (+3.53%) is currently significantly outperforming the market (+2.2% vs SPY). Today, the S&P 500 (SPY) is up 1.32%, and Nasdaq (QQQ) is up 2.31%.

What does MACD indicate for MAZE?

MAZE's MACD (1.95) is currently above the signal line (1.57), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 31.9) is strong.

Is MAZE in an uptrend or downtrend?

Based on moving average analysis, MAZE is in a bullish trend. The price ($36.70) is trading above both the 20-day SMA ($32.02) and 50-day SMA ($28.33). This alignment typically indicates sustained upward momentum.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL